Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Ramucirumab

Hazard - P - B - T - Risk Exempt

Information

Assessment report

Assessment report for Cyramza (ramucirumab), 17 December 2015, EMA/CHMP/69143/2016.

"No ERA was submitted."

Fass environmental information

Fass environmental information for Cyramza from Lilly (downloaded 2019-09-04).

Detailed information

According to the European Medicines Agency guideline on environmental risk assessments for pharmaceuticals (EMA/CHMP/SWP/4447/00), vitamins, electrolytes, amino acids, peptides, proteins, carbohydrates, lipids proteins, vaccines and herbal medicinal products are exempted because they are unlikely to result in significant risk to the environment.

Author: Health and Medical Care Administration, Region Stockholm